In this ‘special edition’ episode, Steve Durbin sits down with Oliver Kemp, MBE and CEO of Prostate Cancer Research (PCR) for an honest discussion about prostate cancer, from who’s at risk and recognising early signs to why timely action can make such a meaningful difference.
Together, they share insights and guidance tips while highlighting the role AI technology plays in prostate cancer research. Also, how ISF’s partnership with PCR aims to raise awareness, improve access to trustworthy information and support informed decision‑making across the cyber security community.
And for people in cyber security, it’s about being as proactive about your own health as you are about protecting your organisation. – Steve Durbin, Chief Executive, ISF
- What PSA is and how testing for prostate cancer is done (5:28)
- The new partnership between ISF and PCR (18:58)
- How AI and new technologies can help in cancer detection (22:34)
Enhance your listening experience
Follow along with our podcast transcript and discover related ISF resources.